Review
Accepted on 21 Jul 2025
Advancing Equity in Allergy and Immunology: Progress, Pitfalls, and the Path Forward
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1639718
- 190 views
Type at least 3 characters
34 articles
Correction
Published on 14 Jul 2025
Correction: Multi-omics technology reveals the changes in gut microbiota to stimulate aromatic amino acid metabolism in children with allergic rhinitis and constipation
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1655751
- 439 views
Case Report
Published on 02 Jul 2025
Case reports of subcutaneous pdC1INH in pregnancy and lactation: expanding treatment options for hereditary angioedema in Portugal
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1604440
- 696 views
Original Research
Published on 23 May 2025
Steroid-sparing benefits of biologic use in hypereosinophilic syndrome and substantial disease burden across subtypes
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1605397
- 1,248 views
Original Research
Published on 13 May 2025
Real world evidence of dupilumab effectiveness in a Colombian cohort of patients diagnosed with severe asthma
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1564033
- 1,527 views
Original Research
Published on 09 May 2025
Multi-omics technology reveals the changes in gut microbiota to stimulate aromatic amino acid metabolism in children with allergic rhinitis and constipation
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1562832
- 1,666 views
Clinical Trial
Published on 10 Apr 2025
A randomized controlled trial evaluating prophylactic treatment of Artemisia pollinosis using azelastine hydrochloride and fluticasone propionate nasal spray
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1559201
- 1,256 views
Editorial
Published on 04 Apr 2025
Editorial: Allergies and anti-allergy drug discovery in Africa
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1593023
- 706 views
Original Research
Published on 27 Feb 2025
Profiling of the gut, skin and nasal microbiotas revealed clinically relevant microbial taxa from children with allergies: a pilot study
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1497914
- 1,648 views
Correction
Published on 14 Feb 2025
Corrigendum: A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1557356
- 894 views
Original Research
Published on 28 Nov 2024
Spectrum of offending drugs and cutaneous adverse drug reactions requiring hospitalisation in a tertiary South African hospital in TB/HIV endemic setting
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2024.1481281
- 1,703 views
Original Research
Published on 02 Oct 2024
The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2024.1464466
- 1,700 views
Original Research
Published on 25 Sep 2024
Correlation between forkhead box P3 (rs3761548) gene polymorphism and serum interleukin13 as biomarkers of severity in Egyptian allergic conjunctivitis: a retrospective study
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2024.1437600
- 1,385 views
- 1 citation
Case Report
Published on 19 Sep 2024
The management of exercise-induced anaphylaxis in a Chinese child with biologics: a case report
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2024.1453873
- 1,833 views
Original Research
Published on 17 Sep 2024
A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2024.1436855
- 3,224 views
- 1 citation
Editorial
Published on 23 Aug 2024
Editorial: The safety, efficacy, and effectiveness of allergen-specific oral immunotherapy
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2024.1448220
- 1,051 views